Global Next Generation Sequencing Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR022507790

Publication Date:

February 24, 2025

Pages:

117

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Next Generation Sequencing market size was valued at US$ 3945 million in 2024 and is forecast to a readjusted size of USD 4947 million by 2031 with a CAGR of 3.3% during review period.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
This report is a detailed and comprehensive analysis for global Next Generation Sequencing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Next Generation Sequencing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Next Generation Sequencing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Next Generation Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Next Generation Sequencing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next Generation Sequencing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next Generation Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Next Generation Sequencing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Market segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
Market segment by players, this report covers
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Next Generation Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next Generation Sequencing, with revenue, gross margin, and global market share of Next Generation Sequencing from 2020 to 2025.
Chapter 3, the Next Generation Sequencing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Next Generation Sequencing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Sequencing.
Chapter 13, to describe Next Generation Sequencing research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next Generation Sequencing by Type
1.3.1 Overview: Global Next Generation Sequencing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Next Generation Sequencing Consumption Value Market Share by Type in 2024
1.3.3 Targeted Sequencing & Resequencing
1.3.4 Whole Genome Sequencing
1.3.5 Whole Exome Sequencing
1.4 Global Next Generation Sequencing Market by Application
1.4.1 Overview: Global Next Generation Sequencing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Whole-genome Sequencing
1.4.3 Exome Sequencing
1.4.4 Targeted Resequencing
1.4.5 De Novo Sequencing
1.4.6 RNA Sequencing
1.4.7 ChIP Sequencing
1.4.8 Methyl Sequencing
1.4.9 Others
1.5 Global Next Generation Sequencing Market Size & Forecast
1.6 Global Next Generation Sequencing Market Size and Forecast by Region
1.6.1 Global Next Generation Sequencing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Next Generation Sequencing Market Size by Region, (2020-2031)
1.6.3 North America Next Generation Sequencing Market Size and Prospect (2020-2031)
1.6.4 Europe Next Generation Sequencing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Next Generation Sequencing Market Size and Prospect (2020-2031)
1.6.6 South America Next Generation Sequencing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Next Generation Sequencing Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 454 Life Sciences Corporation (A Roche Company)
2.1.1 454 Life Sciences Corporation (A Roche Company) Details
2.1.2 454 Life Sciences Corporation (A Roche Company) Major Business
2.1.3 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Product and Solutions
2.1.4 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 454 Life Sciences Corporation (A Roche Company) Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Next Generation Sequencing Product and Solutions
2.2.4 Agilent Technologies Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Biomatters, Ltd
2.3.1 Biomatters, Ltd Details
2.3.2 Biomatters, Ltd Major Business
2.3.3 Biomatters, Ltd Next Generation Sequencing Product and Solutions
2.3.4 Biomatters, Ltd Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Biomatters, Ltd Recent Developments and Future Plans
2.4 CLC Bio
2.4.1 CLC Bio Details
2.4.2 CLC Bio Major Business
2.4.3 CLC Bio Next Generation Sequencing Product and Solutions
2.4.4 CLC Bio Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 CLC Bio Recent Developments and Future Plans
2.5 GATC biotech AG
2.5.1 GATC biotech AG Details
2.5.2 GATC biotech AG Major Business
2.5.3 GATC biotech AG Next Generation Sequencing Product and Solutions
2.5.4 GATC biotech AG Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 GATC biotech AG Recent Developments and Future Plans
2.6 Macrogen
2.6.1 Macrogen Details
2.6.2 Macrogen Major Business
2.6.3 Macrogen Next Generation Sequencing Product and Solutions
2.6.4 Macrogen Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Macrogen Recent Developments and Future Plans
2.7 BGI (Beijing Genomics Institute)
2.7.1 BGI (Beijing Genomics Institute) Details
2.7.2 BGI (Beijing Genomics Institute) Major Business
2.7.3 BGI (Beijing Genomics Institute) Next Generation Sequencing Product and Solutions
2.7.4 BGI (Beijing Genomics Institute) Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 BGI (Beijing Genomics Institute) Recent Developments and Future Plans
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Next Generation Sequencing Product and Solutions
2.8.4 Illumina Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Illumina Recent Developments and Future Plans
2.9 Life Technology Corporation
2.9.1 Life Technology Corporation Details
2.9.2 Life Technology Corporation Major Business
2.9.3 Life Technology Corporation Next Generation Sequencing Product and Solutions
2.9.4 Life Technology Corporation Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Life Technology Corporation Recent Developments and Future Plans
2.10 EMC Corporation
2.10.1 EMC Corporation Details
2.10.2 EMC Corporation Major Business
2.10.3 EMC Corporation Next Generation Sequencing Product and Solutions
2.10.4 EMC Corporation Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 EMC Corporation Recent Developments and Future Plans
2.11 Dnastar
2.11.1 Dnastar Details
2.11.2 Dnastar Major Business
2.11.3 Dnastar Next Generation Sequencing Product and Solutions
2.11.4 Dnastar Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Dnastar Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Next Generation Sequencing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Next Generation Sequencing by Company Revenue
3.2.2 Top 3 Next Generation Sequencing Players Market Share in 2024
3.2.3 Top 6 Next Generation Sequencing Players Market Share in 2024
3.3 Next Generation Sequencing Market: Overall Company Footprint Analysis
3.3.1 Next Generation Sequencing Market: Region Footprint
3.3.2 Next Generation Sequencing Market: Company Product Type Footprint
3.3.3 Next Generation Sequencing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Next Generation Sequencing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Next Generation Sequencing Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Next Generation Sequencing Consumption Value Market Share by Application (2020-2025)
5.2 Global Next Generation Sequencing Market Forecast by Application (2026-2031)
6 North America
6.1 North America Next Generation Sequencing Consumption Value by Type (2020-2031)
6.2 North America Next Generation Sequencing Market Size by Application (2020-2031)
6.3 North America Next Generation Sequencing Market Size by Country
6.3.1 North America Next Generation Sequencing Consumption Value by Country (2020-2031)
6.3.2 United States Next Generation Sequencing Market Size and Forecast (2020-2031)
6.3.3 Canada Next Generation Sequencing Market Size and Forecast (2020-2031)
6.3.4 Mexico Next Generation Sequencing Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Next Generation Sequencing Consumption Value by Type (2020-2031)
7.2 Europe Next Generation Sequencing Consumption Value by Application (2020-2031)
7.3 Europe Next Generation Sequencing Market Size by Country
7.3.1 Europe Next Generation Sequencing Consumption Value by Country (2020-2031)
7.3.2 Germany Next Generation Sequencing Market Size and Forecast (2020-2031)
7.3.3 France Next Generation Sequencing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Next Generation Sequencing Market Size and Forecast (2020-2031)
7.3.5 Russia Next Generation Sequencing Market Size and Forecast (2020-2031)
7.3.6 Italy Next Generation Sequencing Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Next Generation Sequencing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Next Generation Sequencing Market Size by Region
8.3.1 Asia-Pacific Next Generation Sequencing Consumption Value by Region (2020-2031)
8.3.2 China Next Generation Sequencing Market Size and Forecast (2020-2031)
8.3.3 Japan Next Generation Sequencing Market Size and Forecast (2020-2031)
8.3.4 South Korea Next Generation Sequencing Market Size and Forecast (2020-2031)
8.3.5 India Next Generation Sequencing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Next Generation Sequencing Market Size and Forecast (2020-2031)
8.3.7 Australia Next Generation Sequencing Market Size and Forecast (2020-2031)
9 South America
9.1 South America Next Generation Sequencing Consumption Value by Type (2020-2031)
9.2 South America Next Generation Sequencing Consumption Value by Application (2020-2031)
9.3 South America Next Generation Sequencing Market Size by Country
9.3.1 South America Next Generation Sequencing Consumption Value by Country (2020-2031)
9.3.2 Brazil Next Generation Sequencing Market Size and Forecast (2020-2031)
9.3.3 Argentina Next Generation Sequencing Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Next Generation Sequencing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Next Generation Sequencing Market Size by Country
10.3.1 Middle East & Africa Next Generation Sequencing Consumption Value by Country (2020-2031)
10.3.2 Turkey Next Generation Sequencing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Next Generation Sequencing Market Size and Forecast (2020-2031)
10.3.4 UAE Next Generation Sequencing Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Next Generation Sequencing Market Drivers
11.2 Next Generation Sequencing Market Restraints
11.3 Next Generation Sequencing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Next Generation Sequencing Industry Chain
12.2 Next Generation Sequencing Upstream Analysis
12.3 Next Generation Sequencing Midstream Analysis
12.4 Next Generation Sequencing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂